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Abstract 
Background: Malaria control using long‑lasting insecticidal nets (LLINs) and indoor residual spraying of insecticide 
(IRS) has been associated with reduced transmission throughout Africa. However, the impact of transmission reduc‑
tion on the age distribution of malaria cases remains unclear.
Methods: Over a 10‑year period (January 2009 to July 2018), outpatient surveillance data from four health facilities 
in Uganda were used to estimate the impact of control interventions on temporal changes in the age distribution of 
malaria cases using multinomial regression. Interventions included mass distribution of LLINs at all sites and IRS at two 
sites.
Results: Overall, 896,550 patient visits were included in the study; 211,632 aged < 5 years, 171,166 aged 5–15 years 
and 513,752 > 15 years. Over time, the age distribution of patients not suspected of malaria and those malaria nega‑
tive either declined or remained the same across all sites. In contrast, the age distribution of suspected and confirmed 
malaria cases increased across all four sites. In the two LLINs‑only sites, the proportion of malaria cases in < 5 years 
decreased from 31 to 16% and 35 to 25%, respectively. In the two sites receiving LLINs plus IRS, these proportions 
decreased from 58 to 30% and 64 to 47%, respectively. Similarly, in the LLINs‑only sites, the proportion of malaria 
cases > 15 years increased from 40 to 61% and 29 to 39%, respectively. In the sites receiving LLINs plus IRS, these pro‑
portions increased from 19 to 44% and 18 to 31%, respectively.
Conclusions: These findings demonstrate a shift in the burden of malaria from younger to older individuals follow‑
ing implementation of successful control interventions, which has important implications for malaria prevention, 
surveillance, case management and control strategies.
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Background
In Africa, the burden of malaria has decreased signifi-
cantly, primarily through the scale-up of vector control 
interventions, including long-lasting insecticidal nets 
(LLINs), and indoor residual spraying of insecticide (IRS) 
[1–3]. These interventions were coupled with improved 
case management using artemisinin-based combination 
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therapy (ACT), and intermittent preventive therapy with 
sulfadoxine-pyrimethamine for pregnant women [4, 5]. 
Whereas the impact of malaria control interventions is 
generally measured in terms of changes in Plasmodium 
falciparum infection prevalence and case numbers [1], 
more evidence is needed on how interventions influ-
ence the age distribution of malaria cases, a vital marker 
of progress in malaria control [6]. In high transmission 
settings, younger children bear the brunt of the malaria 
burden [7, 8], particularly for severe malaria and malaria 
deaths [9, 10]. However, it is unclear how quickly and 
to what extent the age distribution of uncomplicated 
malaria cases may shift with changes in transmission, 
following the successful implementation of control 
interventions.
Malaria surveillance efforts have generally focused 
on children under 5  years of age, a group that contrib-
utes the majority of reported cases [11] and are thus the 
focus of control measures and research, in areas of stable 
malaria transmission in sub-Saharan Africa. School-aged 
children (5–15 years) have received less attention due to 
the lower morbidity and occurrence of severe outcomes 
in this group [12]. However, older children often experi-
ence low-density asymptomatic infections and have been 
identified as important contributors to the infection res-
ervoir for onward transmission [13]. Even less attention 
is given to adults (over 15  years), except for pregnant 
women [14], despite documented high prevalence of 
asymptomatic infections with high parasitaemia in adults 
[15, 16].
Commitments to malaria control made at the Abuja 
Summit in 2000 [17] led to World Health Organization 
(WHO) recommendations of universal coverage with 
LLINs, beginning in 2007 [18]. In Uganda, access to 
LLINs increased gradually, first among pregnant women 
and children under 5 years of age [19, 20]. This later cul-
minated in universal LLIN campaigns aimed at one LLIN 
for every two household residents [21], with nationwide 
distributions in 2013–2014 [22] and 2017–2018. Further-
more, IRS was implemented in 10 districts effective 2010, 
then shifted to 14 districts from 2014 onwards [23, 24]. 
In northern Uganda, integrated community case man-
agement (iCCM) of malaria began from 2016 to 2017 and 
the 10 districts plus one also resumed IRS [25].
Following the scale-up of malaria control efforts in 
Uganda, confirmed malaria cases reported from health 
facilities declined by an average of 10.8% per year 
between 2013 and 2015 before increasing in 2016 [26]. 
Moreover, malaria indicator surveys (MIS) showed that 
parasite prevalence in children under 5  years of age 
declined from 42% in 2009 to 19% in 2014–2015 [27, 28], 
whilst malaria mortality reportedly decreased from 59 to 
23 deaths per 100,000 between 2010 and 2017 [25].
This study aimed to investigate the impact of control 
interventions on the age distribution of malaria cases, 
using high-quality malaria surveillance data from four 
sites in Uganda, where mass LLIN distribution was con-
ducted at all four sites and IRS implemented at two, one 
of which also received iCCM.
Methods
Malaria surveillance
The National Malaria Control Division (NMCD) of the 
Ministry of Health has conducted surveillance through 
the health management information system (HMIS) 
since 2007. However, more detailed malaria surveil-
lance including collection of individual-level data has 
been conducted in selected malaria reference centres 
(MRCs) since 2006. MRCs are level III or IV health 
facilities located across the country, representing varied 
transmission settings as previously described [29, 30]. 
In summary, patients visiting these centres are assessed 
at the outpatient department (OPD) and basic informa-
tion recorded using an OPD registry, including history 
of fever, age, gender, malaria diagnostic test results, and 
treatments prescribed. Individual visit-level OPD records 
are then entered into an MS Access database (Micro-
soft Corporation, Redmond, WA, USA) and sent to the 
Uganda Malaria Surveillance Programme (UMSP) data 
centre and cleaned before transfer to STATA (Stata Cor-
poration, College Station, TX, USA) for analysis. Data 
from these sites are used to generate monthly reports 
that are shared and reviewed by the NMCD and other 
stakeholders.
Study sites
Four MRCs were selected for this study including: 
Walukuba in Jinja District, Kasambya in Mubende Dis-
trict, Aduku in Apac District, and Nagongera in Tororo 
Distict (Fig.  1). These sites were purposively selected 
because of their temporal representation of the malaria 
indicators of interest, with data covering the period 
of interest (January 2009 and July 2018), and have had 
malaria control intervention activities implemented 
in each of them. By transmission settings, Walukuba 
and Kasambya had an estimated annual entomological 
inoculation rate (aEIR) of less than 10 infective bites per 
person per year in the early 2000s, while in Aduku and 
Nagongera aEIR was in excess of 1500 and 550, respec-
tively [31].
Variable description
Records in the database were classified either as ‘sus-
pected malaria’ or ‘no suspected malaria’. Suspected 
malaria was defined as patients who: (a) had a laboratory 
test done for malaria (microscopy or rapid diagnostic test 
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(RDT)); or, (b) were given a clinical diagnosis of malaria 
in the absence of laboratory testing. All records that did 
not meet this definition were classified as ‘no suspected 
malaria’.
Among suspected malaria cases, ‘malaria cases’ were 
defined as all those patients with positive malaria diag-
nostic test results (microscopy or RDT). Moreover, 
‘malaria negative cases’ were those who were tested 
for malaria (microscopy or RDT) but had negative test 
results.
Description of malaria control interventions at the study 
sites
Using available information from the NMCD on when 
specific interventions were implemented and/or inter-
rupted at each study site, calendar time was divided 
into three to four different intervention periods per site 
(Fig. 2). The first period for each site, before large-scale 
interventions were implemented, is referred to as base-
line. During baseline periods, control activities were 
largely limited to targeted distribution of insecticide-
treated nets (ITNs) to vulnerable populations such as 
children under 5 years of age and pregnant mothers [32, 
33]. The subsequent intervention periods were then used 
to quantify the impact of interventions on the age-distri-
bution of test-confirmed malaria cases.
The main control interventions implemented in 
Walukuba and Kasambya were two mass LLIN distribu-
tion campaigns conducted in 2013 and 2017 at both sites. 
In addition to LLINs in the same time periods, Aduku 
and Nagongera also received IRS. The baseline period 
in Aduku included one round of IRS with the pyrethroid 
alphacypermethrin insecticide, which was not consid-
ered to be effective due to insecticide resistance [30]. 
This period in Aduku, was followed by nine rounds of IRS 
with the carbamate bendiocarb insecticide approximately 
every 6 months, as well as the first mass LLIN distribu-
tion campaign. IRS was stopped for 3  years and then a 
single round of IRS with the organophosphate Actellic 
insecticide was conducted, immediately followed by the 
second mass LLIN distribution campaign. In Nagongera, 
the baseline period was followed by the first mass LLIN 
distribution campaign and then a sustained period of IRS 
including three rounds with the bendiocarb insecticide, 
approximately every 6 months, followed by three rounds 
with Actellic approximately every 12  months. A second 
mass LLIN distribution campaign was also conducted in 
Nagongera during the sustained period of IRS [34].
Statistical analysis
Data from patients with age missing (0.3%), age over 
70  years (1.2%), and follow-up visits for any previously 
recorded illness episode (0.7%) were excluded from the 
analyses. First, data were explored by calculating, for 
each site and intervention period, the total number of 
patients seen and the proportion of those that were sus-
pected, tested and classified as confirmed malaria cases. 
To characterize changes in testing practices, proportion 
of cases that were tested by microscopy vs RDT were cal-
culated. Test positivity rate (TPR) was defined as the pro-
portion of patients tested for malaria that tested positive, 
a metric often considered a viable proxy for transmission 
intensity [35].
Trends in the gender distribution of patients with or 
without suspected malaria and malaria cases were also 
explored across intervention periods using cross-tabula-
tion with Chi squared tests.
To characterize the impact of control interventions 
on the age distribution of malaria cases, first, vio-
lin density plots were used to visualize changes over 
the intervention periods and compare the distribu-
tions of patients not suspected of malaria to those with 
confirmed malaria. Second, scatter plots of age (as a 
continuous variable) and test positivity, stratified by 
intervention periods, per site were examined. Third, 
multinomial logistic regression models were fit, by site. 
The outcome in these models was ‘the age category of 
Fig. 1 Site locations of the four study health facilities categorized by 
the main intervention activity used
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confirmed malaria cases’ (under 5  years, 5–15  years, 
and over 15 years; three age categories being conveni-
ently defined), while the main predictor was the inter-
vention period. Models were adjusted for diagnostic 
test used (microscopy vs RDT), as well as patient gen-
der. To validate the potential impact of increasing use 
of RDTs across sites over time on these findings, the 
multinomial regression models were fit with an inter-
action between diagnostic test and time. Using the full 
models, adjusted proportions of malaria cases in each 
of the age categories per intervention period were pre-
dicted. These marginal predictions were made at the 
mean values of the variables included in the model and 
analyses performed in R [36] and STATA 15 (Stata Cor-
poration 2017, College Station, TX, USA).
Fig. 2 Intervention periods, and TPR trends by age category (< 5, 5–15 and > 15 years) and site. Intervention periods, defined based on malaria 
control activities per site: Walukuba: LLINs alone. Period 1 (Jan 2009–Oct 2013): Prior to the first mass LLIN distribution campaign conducted 
during October 2013. Period 2 (Nov 2013–May 2017): Post first mass LLIN distribution and prior to second distribution campaign conducted 
during May 2017. Period 3 (Jun 2017–Jul 2018): Post second mass LLIN campaign to study endline. Kasambya: LLINs alone. Period 1 (Jan 2009–
Nov 2013): Prior to first mass LLIN distribution campaign conducted during November 2013. Period 2 (Dec 2013–Nov 2017): Post first mass LLIN 
distribution campaign and prior to second distribution campaign conducted during November 2017. Period 3 (Dec 2017–Jul 2018): Post second 
mass distribution campaign to study endline. Aduku: LLINs, IRS and iCCM. Period 1 (Jan 2009–Aug 2010): One IRS round with the pyrethroid 
alpha‑cypermethrin insecticide was implemented in March 2010. Period 2 (Sep 2010–Apr 2014): Received intense IRS campaign with nine rounds 
of carbamate bendiocarb approximately 6‑monthly, the last of which was conducted during May 2014. The first mass LLIN distribution campaign 
was also conducted in July 2014. Period 3 (May 2014–May 2017): IRS withdrawal for 3 years till one round of IRS with the organophosphate Actellic 
insecticide conducted during May 2017. The second mass LLIN distribution campaign was also conducted over this period and iCCM implemented 
effective 2016. Period 4 (Jun 2017–Jul 2018): Post last round of IRS (May 2017) to study endline. Nagongera: LLINs and IRS. Period 1 (Jan 2009–Nov 
2013): Prior to first mass LLIN distribution campaign conducted during November 2013. Period 2 (Dec 2013–Jan 2015): Post first mass distribution 
and prior to first IRS campaign conducted during January 2015. Period 3 (Feb 2015–Jul 2018): Period where six rounds of IRS were conducted, three 
rounds with bendiocarb approximately 6‑monthly followed by three rounds with Actellic approximately 12‑monthly, as well as the second mass 
LLIN distribution campaign conducted in May 2017
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Results
Patient composition and attendance by site
Between January 2009 and July 2018, the four health 
facilities of Walukuba, Kasambya, Aduku, and Nagongera 
recorded 896,550 patient visits in their outpatient depart-
ment clinic registers, with over half of them (53%) sus-
pected to be malaria cases. Walukuba recorded the 
highest number of both patient attendance (323,856) and 
suspected malaria cases (130,296), while Kasambya had 
the lowest attendance at 153,811 (Table 1).
The highest annual mean number of patients seen was 
in Walukuba (33,053) followed by Nagongera (22,701), 
then Aduku (20,079), and least in Kasambya (15,897). 
Mean monthly patient attendance per year remained 
fairly constant at all sites except Walukuba where this 
value peaked in 2011 at 3400 and steadily declined to 
1952 by 2018 (Fig. S1, Additional file 1). Mean monthly 
attendance of patients not suspected of malaria per year 
increased slowly over time at all sites with cyclic varia-
tions (Fig.  S2, Additional file  1). From 2009 to 2018, 
these increases were significant in Kasambya and Aduku 
though not in Walukuba or Nagongera by Wilcoxon 
rank-sum test (Table  S1, Additional file  1). Conversely, 
mean monthly attendance of suspected malaria cases per 
year followed a general decline over time at all sites with 
cyclic variations (Fig. S3, Additional file 1). From 2009 to 
2018, these declines were significant in Walukuba, Aduku 
and Nagongera, but not in Kasambya (Table  S1, Addi-
tional file 1).
The majority of non-suspected and suspected malaria 
cases were female (67 and 63%, respectively). The differ-
ence between gender among confirmed malaria cases was 
smallest among children under 5  years of age (per cent 
female: Aduku 49%, Nagongera 49%, Walukuba 54%, and 
Kasambya 55%) and largest among patients over 15 years 
of age (per cent female: Aduku 79%, Nagongera 75%, 
Walukuba 63%, and Kasambya 66%). No observable trend 
in gender overall was found across intervention periods.
Trends in diagnostic testing over time
Throughout the study period, the majority of labora-
tory testing for malaria was by microscopy (89%) and the 
highest and lowest overall testing rates (percentage of 
suspected malaria cases that received a diagnostic test for 
malaria) were observed in Walukuba (97%) and Aduku 
(93%), respectively. Across intervention periods however, 
the proportion tested by RDT increased at all four sites 
mostly in the last 4  years of study duration. By the last 
period, 77% of cases were tested by RDT in Kasambya, 
72% in Aduku, 40% in Nagongera, and 25% in Walukuba 
(Fig. S4, Additional file 1).
Test positivity rates
Although Aduku and Nagongera were historically the 
highest transmission settings, the highest TPR was 
observed in Aduku followed by Kasambya, Nagongera 
and Walukuba (Table 1). When considering only children 
under 5 years of age, however, baseline TPR levels were 
reflective of the historical transmission intensities. Base-
line TPR in this group was highest at Nagongera (64%) 
and Aduku (63%), and lower in Kasambya (37%) and 
Walukuba (31%).
In all four sites, control interventions were associ-
ated with moderate reduction in overall TPR with 
Table 1 Malaria-associated demographics of study participants for each site, by intervention period
a Patients seen at the health facility excluding those with a missing record of age
b Testing for malaria includes both microscopy and RDT
Site Intervention period Total  observationsa Suspected malaria 
(%)
Tested for malaria 
(%)b
Microscopy (%) Positive test result 
(%)b
Walukuba Jan 2009–Oct 2013 183,327 95,080 (51.9%) 92,784 (97.6%) 92,738 (99.9%) 30,785 (33.2%)
Nov 2013–May 2017 111,506 27,483 (24.7%) 26,051 (94.8%) 24,360 (93.5%) 9239 (35.5%)
Jun 2017–Jul 2018 29,023 7733 (26.6%) 7024 (90.8%) 5227 (74.4%) 2037 (29.0%)
Kasambya Jan 2009–Nov 2013 85,200 65,768 (77.2%) 63,479 (96.5%) 60,070 (94.6%) 24,538 (38.7%)
Dec 2013–Nov 2017 60,488 41,823 (69.1%) 38,328 (91.6%) 30,199 (78.8%) 15,996 (41.7%)
Dec 2017–Jul 2018 8123 5272 (64.9%) 5083 (96.4%) 1156 (22.7%) 1529 (30.1%)
Aduku Jan 2009–Aug 2010 34,596 19,024 (55.0%) 17,877 (94.0%) 17,877 (100%) 9921 (55.5%)
Sep 2010–Apr 2014 71,329 40,428 (56.7%) 40,277 (99.6%) 39,056 (97.0%) 9825 (24.4%)
May 2014–May 2017 66,092 34,467 (52.2%) 29,410 (85.3%) 17,466 (59.4%) 15,311 (52.1%)
Jun 2017–Jul 2018 25,389 9013 (35.5%) 8158 (90.5%) 2280 (28.0%) 2189 (26.8%)
Nagongera Jan 2009–Nov 2013 124,711 82,762 (66.4%) 76,915 (92.9%) 74,959 (97.5%) 27,007 (35.1%)
Dec 2013–Jan 2015 24,530 15,893 (64.8%) 15,723 (98.9%) 14,874 (94.6%) 3977 (25.3%)
Feb 2015–Jul 2018 72,236 27,297 (37.8%) 27,064 (99.2%) 16,213 (59.9%) 4309 (15.9%)
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acyclic secular trends in between. Larger reductions 
were observed in the two sites where both LLINs and 
IRS were implemented (Fig. 2). In these sites, the declin-
ing trend in TPR is consistent except in Aduku, during 
the 3  years of withdrawn IRS, characterized by a sharp 
increase. Between baseline and the last intervention 
periods, TPR declined in Aduku from 56 to 27% and in 
Nagongera from 35 to 16%. In the two sites that received 
LLINs only, a similarly (with acyclic secular but less nota-
bly) reducing trend was observed. Between baseline and 
the last intervention periods, overall TPR decreased in 
Walukuba from 33 to 29% and in Kasambya from 39 to 
30% (Table 1).
Over time and in all four sites, test positivity was seen 
to decline among the younger children while increasing 
among older participants. In all sites, a shift in the peak 
age of test positivity from the youngest to the older ages, 
was observed between baseline and last intervention 
period (Figs.  S5 and S6, Additional file  1). Interestingly, 
this pattern was reversed in Aduku during the 3  years 
when IRS was withdrawn, further confirming the effect of 
control interventions on test positivity with age (Fig. S6, 
Additional file 1).
Differences in age distribution of malaria cases 
between sites at baseline
Although the duration of baseline periods varied between 
the sites due to the different timing of intervention activi-
ties, the age distribution of patients not suspected of 
malaria was very similar between all four sites at baseline, 
with median ages ranging from 23 to 25 years (Fig. 3). In 
contrast, the age distributions of malaria cases varied sig-
nificantly between sites. These distributions were similar 
between the highest transmission sites of Nagongera and 
Aduku, with median ages of 2 and 3 years, respectively. 
The distributions were also similar, but higher, between 
the lower transmission sites, with median ages of 8 and 
11 years for Kasambya and Walukuba, respectively.
Consistent with unadjusted analyses, results from the 
final adjusted multinomial regression models (adjust-
ing for diagnostic test and gender of patient; evaluated 
using Akaike’s information criteria and likelihood ratio 
tests (Table S2, Additional file 1) for model selection; and, 
using scatter plots with fitted lines for goodness of fit 
(Fig. S7, Additional file 1) showed that the proportion of 
malaria cases per age-group were significantly different 
between sites at baseline. The majority of malaria cases 
were among children under 5  years of age in the high-
est transmission sites (Aduku 58% and Nagongera 64%), 
while the highest proportion of malaria cases was among 
patients 5–15 years of age in Kasambya (35%), and over 
15 years of age in Walukuba (31%) (Fig. 4).
Changes in age distribution of non‑suspected, 
test‑negative, and laboratory confirmed malaria cases 
over time
The age of patients not suspected of malaria decreased 
slightly over the study duration at all four sites. Moreo-
ver, for malaria negative patients, the age distribution 
slightly shifted downwards and then upwards at all sites 
except Nagongera, where it shifted downwards across 
the intervention periods. In contrast, the age distri-
bution of patients with laboratory confirmed malaria 
shifted upwards over time at all four sites. Comparing 
the last observation period to baseline, the median age 
of patients with malaria increased from 8 (IQR: 2.5–19) 
to 11 (IQR: 5–21) in Kasambya; 11 (IQR: 3.5–24) to 22 
(IQR: 8–32) in Walukuba; 2 (IQR: 1.1–10) to 6 (IQR: 
2–18) in Nagongera; and 3 (IQR: 1.2–13) to 14 (IQR: 
5–22) in Aduku (Fig. 3).
Across all sites, a progressive decline in the propor-
tion of malaria cases from the youngest age group and 
a progressive increase in the proportion of cases from 
the oldest age group were observed. Comparing the last 
intervention period to baseline, the adjusted proportion 
of malaria cases among children under 5  years of age 
decreased from 58% (95% CI 57–59%) to 30% (95% CI 
28–31%) in Aduku; 31% (95% CI 30–31%) to 16% (95% CI 
15–17%) in Walukuba; 64% (95% CI 63–65%) to 47% (95% 
CI 45–48%) in Nagongera; and 35% (95% CI 34–36%) 
to 25% (95% CI 23–27%) in Kasambya. Comparing the 
same periods, the proportion of malaria cases among 
patients over 15 years of age increased from 19% (95% CI 
19–20%) to 44% (95% CI 42–46%) in Aduku; 40% (95% 
CI 40–41%) to 61% (95% CI 59–64%) in Walukuba; 18% 
(95% CI 17–18%) to 31% (95% CI 29–32%) in Nagongera; 
and, 29% (95% CI 28–29%) to 39% (95% CI 37–41%) in 
Kasambya.
The upward shift in the age distribution of malaria 
cases occurred gradually throughout the study peri-
ods in all sites except Aduku, where IRS was withdrawn 
in 2014 for three years (defining the  3rd intervention 
period) before another round was implemented in 2017. 
In Aduku, during the intervals from the 2nd to the 3rd 
intervention periods, the proportion of malaria cases 
among children under 5 years of age increased from 38% 
(95% CI 37–39%) to 44% (95% CI 43–44%), followed by 
a decrease to 30% (95% CI 28–31%) following the last 
round of IRS. At this site, the proportion of malaria cases 
among patients over 15 years decreased from 35% (95% 
CI 34–36%) during the 2nd to 30% (95% CI 29–31%) dur-
ing the 3rd intervention period, before increasing to 44% 
(95% CI 42–46%) in the last period (Fig. 4).
The upward shift in age distribution of confirmed 
malaria occurred consistently in both males and females 
(Fig.  S8, Additional file  1). Whilst the majority of all 
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patients, non-suspected and suspected malaria cases 
were female across the study durations, small differ-
ences were observed in age distribution between males 
and females that were not suspected to be malaria cases 
(Fig.  S9, Additional file  1), but the age distribution of 
females was older than that of males among malaria-
negative patients across all sites (Fig.  S10, Additional 
file 1). Moreover, models allowing an interaction between 
gender and intervention period suggest greater increase 
in proportion of males than females among confirmed 
malaria cases over time (Fig.  S11 and Table  S3, Addi-
tional file 1).
Overall, Aduku experienced the largest change in the 
age distribution of malaria cases throughout the study 
period. The odds of an upward shift in the age category 
of confirmed malaria cases in the last relative to the base-
line intervention periods were 3.27 (95% CI 2.97–3.61) in 
Aduku, 2.35 (95% CI 2.14–2.58) in Walukuba, 2.03 (95% 
CI 1.90–2.17) in Nagongera, and 1.59 (95% CI 1.44–1.76) 
in Kasambya (Table 2). Whereas the interaction between 
Fig. 3 Categorized age distribution across intervention periods, by patient status (not suspected, malaria negative vs confirmed)
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intervention time and diagnostic test used was significant 
in Kasambya and Nagongera, the same did not notably 
impact the overall effect observed (Table S4, Additional 
file  1). Also, RDT use increased gradually at all sites, 
reaching 20% only in the last three to four years of the 
study except Aduku (Fig. S4, Additional file 1).
Discussion
The impact of reductions in malaria transmission follow-
ing the scale-up of malaria control interventions on the 
age distribution of malaria cases, was investigated using 
routine surveillance data from four sentinel health facili-
ties in Uganda. The study included data from sites with 
historically varied transmission intensity where large-
scale programmatic control interventions of either LLINs 
alone or LLINs plus IRS were implemented over the 
approximately 10-year study period.
Study findings provide empirical evidence of rapid 
shifts in the malaria burden to older individuals, fol-
lowing implementation of effective malaria control 
interventions. Over time, the proportion of test con-
firmed malaria cases progressively decreased in children 
under 5  years of age while it progressively increased in 
those over 15  years of age, irrespective of transmis-
sion settings. This is also reflected by subtle but greater 
decline in TPR among children than adults. The absence 
of similar changes in age patterns among patients not 
suspected of malaria suggests that the primary drivers 
of this shift were declines in malaria transmission inten-
sity associated with effective control interventions and 
not changes in patient demographics. The reverse shift 
observed in Aduku during a period of malaria resurgence 
after three years of interrupted IRS [37] provides further 
support for this conclusion.
Many factors may have contributed to the shift in age 
distribution of malaria cases in this study. For many 
endemic infectious diseases, decreases in transmission 
are expected to result in increased age of infection and 
cases [38]. For pathogens like P. falciparum, where par-
tial immunity develops gradually as a consequence of 
Fig. 4 Adjusted marginal probability of confirmed malaria, by intervention period, age and site
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repeated exposure, waning immunity due to decreased 
infection rates may lead to reduced ability to control 
parasites [39]. This waning immunity may result in a rela-
tive increase in the disease burden among adolescents 
and adults [12, 40]. Concentration of the malaria burden 
among older age groups following reduced transmission 
has been predicted in other studies [8], and seen in chil-
dren for both severe and non-severe outcomes [10, 41].
Behavioural factors may have also contributed to rapid 
shifts in the age distribution of malaria. A reduced pro-
portion of cases among children under 5  years of age 
may have been due to an increased use of LLINs among 
this age group relative to older age groups [22, 41, 42]. In 
adults, behavioural factors including travel, leisure and 
social activities, and occupational activities such as agri-
culture or night-time work may have increased the risk 
of exposure outside the household as compared to chil-
dren. Travel has been reported as a risk factor for P. fal-
ciparum infection in East and Southern Africa [43, 44] 
and for cases of imported malaria being older than those 
not imported in Southern Africa [45]. Whereas occupa-
tional hazards were not evaluated in this study, consider-
able occupational risk of malaria has been documented 
among mobile male workers in Asia [46, 47] and popula-
tions involved in agriculture in Africa [48, 49].
Results suggest that implementation of LLINs plus IRS 
was associated with larger decreases in transmission and 
larger shifts in age distribution of cases than LLINs alone. 
However, among LLIN-only sites, Walukuba recorded 
a much larger shift than Kasambya and in Walukuba 
the magnitude of the shift was comparable to that of 
Nagongera, a site with both LLINs and IRS. This suggests 
that other non-intervention factors for example urbani-
zation [50] may have contributed to the shifts, consistent 
with other reported findings [38, 51].
Findings from this study showed that a significantly 
higher proportion of females, as compared to males, 
seem to seek care for febrile illnesses among the school 
aged (5–15  years) and adults (over 15  years old) at all 
sites. This is consistent with the generally older age dis-
tribution of females among both the confirmed and the 
negative malaria cases, but similar age distribution of 
males and females among those not suspected of malaria. 
However, shifts in the age distribution of malaria cases 
observed after control interventions seem to have dis-
proportionately affected males, suggesting a role of 
gender-based occupational or behavioural differences. 
Nevertheless, reported greater involvement of females in 
agriculture in the region [52] than males, as well as docu-
mented associations between occupation and education 
status of mothers and malaria infection risk of families 
[53] may explain the prevailing significantly high propor-
tion of older females and hence the need for continued 
interventions that address this vulnerable group.
This study had limitations. First, without well-defined 
catchment populations for the study sites, it was not pos-
sible to estimate changes in malaria incidence over time 
or effects of environmental factors within the catchment 
areas and limiting the study to describing temporal shifts 
in the age distribution of laboratory confirmed cases 
of malaria. Additional research is necessary to deter-
mine impacts of reduced transmission on incidence of 
malaria. Second, the increased use of RDTs over time, 
may have influenced results from this study through var-
ied sensitivity [54]. Nevertheless, in regression analyses, 
Table 2 Association between  being malaria confirmed 
within ages (< 5, 5–15, > 15 years) and control intervention 
period
Factor Categories Odds 95% CI P value
Walukuba
 Gender Male 1 Ref
Female 1.34 1.29–1.39 < 0.001
 Malaria test done Microscopy 1 Ref
RDT 2.11 0.61–7.26 0.237
 Intervention period Baseline 1 Ref
First period 1.55 1.48–1.62 < 0.001
Last period 2.27 2.05–2.51 < 0.001
Kasambya
 Gender Male 1 Ref
Female 1.39 1.34–1.45 < 0.001
 Malaria test done Microscopy 1 Ref
RDT 0.98 0.93–1.03 0.368
 Intervention period Baseline 1 Ref
First period 1.39 1.34–1.44 < 0.001
Last period 1.59 1.44–1.76 < 0.001
Aduku
 Gender Male 1 Ref
Female 2.64 2.54–2.75 < 0.001
 Malaria test done Microscopy 1 Ref
RDT 1.26 1.19–1.32 < 0.001
 Intervention period Baseline 1 Ref
First period 2.23 2.11–2.35 < 0.001
Second period 1.78 1.68–1.89 < 0.001
Last period 3.27 2.97–3.61 < 0.001
Nagongera
 Gender Male 1
Female 2.18 2.09–2.28 < 0.001
 Malaria test done Microscopy 1
RDT 1.24 1.15–1.34 < 0.001
 Intervention period Baseline 1
First period 1.19 1.11–1.27 < 0.001
Last period 2.03 1.90–2.17 < 0.001
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diagnostic test used was accounted for. Moreover, pat-
terns seen among suspected and confirmed cases were 
absent in the cases not suspected of malaria, suggesting 
that the impact of diagnostic method would be mini-
mal. Third, inability to account for levels of uptake of the 
interventions implemented at the four study sites could 
have masked some important variations. However, the 
community-wide benefit of reduced vector populations 
[55], coupled with the multiple rounds of interventions, 
was believed to have mitigated this effect and thus its 
impact on these results. Fourth, whereas fever or history 
of fever in the past 48 h is the main indicator of suspected 
malaria, this specific measure was not consistently 
recorded in the health facilities, and so inconsistency in 
consideration of the diagnosis may have impacted results 
from this study. Nevertheless, other proxy indicators of 
suspected malaria were also considered to ensure a fairly 
complete capture of these cases. Lastly, having analysed 
health facility surveillance data, this would only include 
participants that seek care in the public health facilities. 
As such community level interventions, especially iCCM 
that target young children could have had an impact on 
these findings. However, iCCM was limited to one of the 
four sites and for less than 2 years.
Conclusions
The findings from this study have important implications 
regarding targeted malaria control interventions that 
have historically focused on children under 5 years of age. 
Whereas these efforts need to continue, new strategies 
may be necessary to address the shift in burden to older 
age groups following the implementation of successful 
malaria control interventions. For instance, extending 
iCCM for malaria to older age groups after intensive IRS, 
with the post-IRS duration often associated with malaria 
resurgence. These findings also have implications for the 
optimal allocation of health care resources for the diag-
nosis, treatment and control of malaria amidst changing 
transmission. Further, they highlight the usefulness of 
considering age distribution in surveillance and monitor-
ing change, and the role of surveillance in understanding 
the epidemiology of malaria.
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